|
|
Article: Screening battery validated for HIV-related neurocognitive impairment.
- Article from:
- Virus Weekly
- Article date:
- November 16, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 NOV 16 - (NewsRx.com & NewsRx.net) -- A screening battery has been validated for persons with HIV-related neurocognitive impairment.
According to researchers in the United States, "This study sought to develop and validate a screening battery for detecting HIV-related neuropsychological (NP) impairment."
"Six NP measures representing the ability areas most likely affected by HIV infection were paired in 14 combinations and their diagnostic accuracy rates compared. The measures were selected from a larger NP battery administered to 190 HIV-seropositive (HIV+) participants.
"Screening battery performance was classified as NP impaired if ...